Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04489303 · ClinicalTrials.gov registry record · Phase 2
Virtual Patient Behavioral Response Training for Family Caregivers
A Phase 2 study, sponsored by Photozig.
- Completed
- Registry status
- Phase 2
- Development phase
- 156
- Enrollment target
NCT04489303: Completed Phase 2 study, sponsored by Photozig.
NCT04489303 is a Phase 2 study that has completed, run by Photozig. The registered enrollment target is 156 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04489303, a Phase 2 study, has completed, sponsored by Photozig.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 156 participants
- Enrollment target
Study Summary
Our study is designed to help caregivers of someone with Alzheimer's Disease and related dementia to understand and deal with the difficult behaviors of a person with dementia.
Primary Outcome
This scale measures the type/number of dementia patients disturbing behaviors, and how much they bother caregivers with 24 items describing possible troublesome behaviors that the patient might evidence in the past month. Caregivers are first asked whether the dementia patient had displayed any of these in the time period, and secondly to rate on a 5-point scale (0=not at all; 4= extremely) how much this "bothered or upset" them. A "conditional bother" score is calculated which is the "upset" or
Interventions
- BEHAVIORAL Caring Response App
- BEHAVIORAL Traditional Educational/Resources Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2020-05-15 |
| Est. Completion | 2021-05-30 |
| Phase | Phase 2 |
What the finished NCT04489303 record still lists
NCT04489303 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 2 interventions - of which Caring Response App is the first listed.
NCT04489303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04489303 about?
NCT04489303 is a clinical study titled "Virtual Patient Behavioral Response Training for Family Caregivers". Our study is designed to help caregivers of someone with Alzheimer's Disease and related dementia to understand and deal with the difficult behaviors of a person with dementia.
What is the current status of trial NCT04489303?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2020-05-15. Estimated completion is 2021-05-30.
What interventions are being tested in trial NCT04489303?
The interventions under investigation include: Caring Response App (BEHAVIORAL), Traditional Educational/Resources Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04489303?
This trial is sponsored by Photozig, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04489303's enrollment target sits among peer trials
156 445th of 2000 higher than 1,553 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI